EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways

Pin Gong, Peipei Wang, Sihui Pi, Yuxi Guo, Shuya Pei, Wenjuan Yang, Xiangna Chang, Lan Wang, Fuxin Chen

Frontiers in Pharmacology · 29.04.2026 · 17

DOI: 10.3389/fphar.2026.1842414 ↗

Kurz gefasst

Korrektur in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.04.2026. Verfasst von Pin Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Food and Biotechnology, Shaanxi University of Science and Technology, Xi'an, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Keap1/Nrf2 signaling pathwaycadmiumdiabetic nephropathyp38 MAPK signaling pathwayproanthocyanidins

Autor:innen und Institutionen

  • College of Food and Biotechnology, Shaanxi University of Science and Technology, Xi'an, China.
  • School of Chemistry and Chemical Engineering, Xi'an University of Science and Technology, Xi'an, China.

Zitieren

APA

Gong, P., Wang, P., Pi, S., Guo, Y., Pei, S., Yang, W., Chang, X., Wang, L., & Chen, F. (2026). Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1842414

Vancouver

Gong P, Wang P, Pi S, Guo Y, Pei S, Yang W, et al. Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1842414

BibTeX
@article{Gong2026,
  author = {Gong, Pin and Wang, Peipei and Pi, Sihui and Guo, Yuxi and Pei, Shuya and Yang, Wenjuan and Chang, Xiangna and Wang, Lan and Chen, Fuxin},
  title = {Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1842414}
}
Kostenlos starten →